Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients

NCT00128310 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

252

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Neoplasm Metastasis

Interventions

DRUG: Vinorelbine
DRUG: Gemcitabine

Sponsor

Spanish Breast Cancer Research Group

Collaborators

[object Object]